glp 1 news Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan Jim Cramer dissects how GLP-1

Frequency count categorized three-day average nutrient intake of GLP-1RA participants compared to dietary reference intake

Fill out the form below, and discover the Serve You Rx difference.

Compounding the problem is the fact that insurance companies are reluctant to cover these anti-obesity medications, since theyre considered by many to be vanity drugs, even though overwhelming evidence suggests obesity is linked directly to multiple comorbidities

Most adverse events reflect expected pharmacology interacting with patient context

Future Developments in GLP-1 Research Scientists continue studying new applications for GLP-1 medications

FDA Sends Warning Letters to Telehealth Companies The FDA has recently issued warnings to 30+ telehealth companies regarding the prescribing and promotion of compounded GLP-1 drugs, including semaglutide